Haplotyping by CRISPR-mediated DNA circularization (CRISPR-hapC) broadens allele-specific gene editing
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Haplotyping by CRISPR-mediated DNA circularization (CRISPR-hapC) broadens allele-specific gene editing. / Yu, Jiaying; Xiang, Xi; Huang, Jinrong; Liang, Xue; Pan, Xiaoguang; Dong, Zhanying; Petersen, Trine Skov; Qu, Kunli; Yang, Ling; Zhao, Xiaoying; Li, Siyuan; Zheng, Tianyu; Xu, Zhe; Liu, Chengxun; Han, Peng; Xu, Fengping; Yang, Huanming; Liu, Xin; Zhang, Xiuqing; Bolund, Lars; Luo, Yonglun; Lin, Lin.
I: Nucleic Acids Research, Bind 48, Nr. 5, e25, 2020.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Haplotyping by CRISPR-mediated DNA circularization (CRISPR-hapC) broadens allele-specific gene editing
AU - Yu, Jiaying
AU - Xiang, Xi
AU - Huang, Jinrong
AU - Liang, Xue
AU - Pan, Xiaoguang
AU - Dong, Zhanying
AU - Petersen, Trine Skov
AU - Qu, Kunli
AU - Yang, Ling
AU - Zhao, Xiaoying
AU - Li, Siyuan
AU - Zheng, Tianyu
AU - Xu, Zhe
AU - Liu, Chengxun
AU - Han, Peng
AU - Xu, Fengping
AU - Yang, Huanming
AU - Liu, Xin
AU - Zhang, Xiuqing
AU - Bolund, Lars
AU - Luo, Yonglun
AU - Lin, Lin
PY - 2020
Y1 - 2020
N2 - Allele-specific protospacer adjacent motif (asPAM)-positioning SNPs and CRISPRs are valuable resources for gene therapy of dominant disorders. However, one technical hurdle is to identify the haplotype comprising the disease-causing allele and the distal asPAM SNPs. Here, we describe a novel CRISPR-based method (CRISPR-hapC) for haplotyping. Based on the generation (with a pair of CRISPRs) of extrachromosomal circular DNA in cells, the CRISPR-hapC can map haplotypes from a few hundred bases to over 200 Mb. To streamline and demonstrate the applicability of the CRISPR-hapC and asPAM CRISPR for allele-specific gene editing, we reanalyzed the 1000 human pan-genome and generated a high frequency asPAM SNP and CRISPR database (www.crispratlas.com/knockout) for four CRISPR systems (SaCas9, SpCas9, xCas9 and Cas12a). Using the huntingtin (HTT) CAG expansion and transthyretin (TTR) exon 2 mutation as examples, we showed that the asPAM CRISPRs can specifically discriminate active and dead PAMs for all 23 loci tested. Combination of the CRISPR-hapC and asPAM CRISPRs further demonstrated the capability for achieving highly accurate and haplotype-specific deletion of the HTT CAG expansion allele and TTR exon 2 mutation in human cells. Taken together, our study provides a new approach and an important resource for genome research and allele-specific (haplotype-specific) gene therapy.
AB - Allele-specific protospacer adjacent motif (asPAM)-positioning SNPs and CRISPRs are valuable resources for gene therapy of dominant disorders. However, one technical hurdle is to identify the haplotype comprising the disease-causing allele and the distal asPAM SNPs. Here, we describe a novel CRISPR-based method (CRISPR-hapC) for haplotyping. Based on the generation (with a pair of CRISPRs) of extrachromosomal circular DNA in cells, the CRISPR-hapC can map haplotypes from a few hundred bases to over 200 Mb. To streamline and demonstrate the applicability of the CRISPR-hapC and asPAM CRISPR for allele-specific gene editing, we reanalyzed the 1000 human pan-genome and generated a high frequency asPAM SNP and CRISPR database (www.crispratlas.com/knockout) for four CRISPR systems (SaCas9, SpCas9, xCas9 and Cas12a). Using the huntingtin (HTT) CAG expansion and transthyretin (TTR) exon 2 mutation as examples, we showed that the asPAM CRISPRs can specifically discriminate active and dead PAMs for all 23 loci tested. Combination of the CRISPR-hapC and asPAM CRISPRs further demonstrated the capability for achieving highly accurate and haplotype-specific deletion of the HTT CAG expansion allele and TTR exon 2 mutation in human cells. Taken together, our study provides a new approach and an important resource for genome research and allele-specific (haplotype-specific) gene therapy.
U2 - 10.1093/nar/gkz1233
DO - 10.1093/nar/gkz1233
M3 - Journal article
C2 - 31943080
AN - SCOPUS:85081074686
VL - 48
JO - Nucleic Acids Research
JF - Nucleic Acids Research
SN - 0305-1048
IS - 5
M1 - e25
ER -
ID: 237997037